These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3296007)

  • 1. Inhibition of complement-mediated hepatic thromboxane production by mepacrine, a phospholipase inhibitor.
    Flynn JT
    Prostaglandins; 1987 Feb; 33(2):287-99. PubMed ID: 3296007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of complement-mediated thromboxane production by the perfused rabbit liver: lack of effect of dantrolene sodium.
    Flynn JT
    Prostaglandins Leukot Med; 1987 May; 27(2-3):93-103. PubMed ID: 3475728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zymosan-activated plasma-mediated thromboxane production by the perfused rabbit liver and isolated hepatocytes: involvement of calcium.
    Flynn JT; Hellerman P; Shelly MA
    Prostaglandins; 1990 Oct; 40(4):383-95. PubMed ID: 2281142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by ethanol and mepacrine of phospholipase-dependent prostaglandin release from the isolated perfused rat lung.
    Peers SH; Hoult JR
    Eur J Pharmacol; 1986 Jan; 120(2):145-50. PubMed ID: 3081357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lidocaine on hepatic prostanoid production in vitro following 2,4-dinitrophenol administration.
    Flynn JT
    Adv Shock Res; 1983; 10():149-59. PubMed ID: 6349294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the involvement of prostanoids from Kupffer cells in the mediation of anaphylatoxin C5a-, zymosan-, and lipopolysaccharide-dependent hepatic glucose output and flow reduction.
    Pestel S; Schlaf G; Götze O; Jungermann K; Schieferdecker HL
    Lab Invest; 2003 Dec; 83(12):1733-41. PubMed ID: 14691291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 stimulated release of prostanoids from the isolated, perfused rabbit liver: implications in regional cellular injury.
    Flynn JT; Henry JM; Perkowski S
    Can J Physiol Pharmacol; 1981 Dec; 59(12):1268-73. PubMed ID: 7337880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro.
    Piper PJ; Samhoun MN
    Br J Pharmacol; 1982 Oct; 77(2):267-75. PubMed ID: 6291685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient activation of hepatic glycogenolysis by thrombin in perfused rat livers.
    Yamanaka H; Nukina S; Handler JA; Currin RT; Lemasters JJ; Thurman RG
    Eur J Biochem; 1992 Sep; 208(3):753-9. PubMed ID: 1396679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by complement-activated rat serum in perfused rat liver.
    Muschol W; Püschel GP; Hülsmann M; Jungermann K
    Eur J Biochem; 1991 Mar; 196(2):525-30. PubMed ID: 2007411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mepacrine attenuates pulmonary vasoreactivity in rabbits.
    Shayevitz JR; McShane AJ; Traystman RJ; Gurtner GH
    J Appl Physiol (1985); 1989 Apr; 66(4):1921-6. PubMed ID: 2499570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nerve stimulation and zymosan on glycogenolysis in perfused livers from cold-exposed rats.
    Shiota M; Kurano Y; Mochizuki Y; Kimura K; Ohta M; Sugano T
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G353-9. PubMed ID: 1415548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic actions of chlorpromazine and mepacrine on modulation of hepatic cell injury in the perfused cat liver.
    Araki H; Peck RC; Lefer AM
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):116-25. PubMed ID: 7224715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin biosynthesis and reduced 5-HT uptake after complement-induced endothelial injury in the dog isolated lung.
    Bult H; Heiremans JJ; Herman AG; Malcorps CM; Peeters FA
    Br J Pharmacol; 1988 Apr; 93(4):791-802. PubMed ID: 3291998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thromboxane in cuprophan-induced pulmonary hypertension.
    Cheung AK; Baranowski RL; Wayman AL
    Kidney Int; 1987 May; 31(5):1072-9. PubMed ID: 3599647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep.
    McDonald JW; Ali M; Morgan E; Townsend ER; Cooper JD
    Circ Res; 1983 Jan; 52(1):1-6. PubMed ID: 6687354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological concentrations of epinephrine potentiate thromboxane A2 release from platelets in the isolated rat heart.
    Purchase M; Dusting GJ; Li DM; Read MA
    Circ Res; 1986 Jan; 58(1):172-6. PubMed ID: 3080260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine.
    Xiao YF; Zeind AJ; Kaushik V; Perreault-Micale CL; Morgan JP
    Eur J Pharmacol; 2000 Jul; 399(2-3):107-16. PubMed ID: 10884509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.